PharmiWeb.com - Global Pharma News & Resources
07-Nov-2018

Lipoprotein(a) Foundation Hosts Gala Fundraiser to Celebrate Opening of Lipoprotein Exhibition at the International Museum of Surgical Science

The Lipoprotein(a) Foundation:

WHAT:

     

The Lipoprotein(a) Foundation is hosting a Gala Fundraiser to celebrate the opening of the “Understanding Lipoproteins: Research, Treatment and Relationship to Cholesterol” exhibition at the International Museum of Surgical Science (IMSS)

∙ All proceeds from the Hope Gala go to support the REVEAL Lipoprotein(a) Patient Natural History Registry to further Lp(a) research

∙ Sponsored by Amgen, Inc., Akcea Therapeutics, Denka Seiken, Arrowhead Pharmaceuticals, Kaneka Corporation and IONIS Pharmaceuticals

∙ The Hope Gala will showcase the “Understanding Lipoproteins” Exhibition, which is dedicated to pioneering University of Chicago researcher, Angelo M. Scanu, M.D.

Hope Gala Press Release

 

WHEN:

The Hope Gala: Lp(a) Research From the Bench to the Clinic: Reflections on the Past, the Present and the Future takes place on Saturday, November 10 at 7pm

∙ The “Understanding Lipoproteins” exhibit opens to the public on Monday, November 12

Hope Gala Registration

 

WHERE:

International Museum of Surgical Science (IMSS)

1524. N. Lake Shore Drive, Chicago, IL

 

WHY:

The “Understanding Lipoproteins” exhibit reviews the health impact of lipoproteins, particles in the blood that carry what is often referred to as “bad” and “good” cholesterol

∙ It is estimated that 63 million in the US have inherited high Lp(a)

∙ Lp(a) concentrations can be measured by a simple blood test, but it is not included in most standard lipid panel tests that check cholesterol levels

∙ A study published in JACC shows that the current cholesterol screening will miss 8% of people who have a cardiovascular event whose only risk factor is high Lp(a)

 

WHO:

The following cardiovascular event survivors and cardiovascular disease experts are available to discuss hereditary risks of cardiovascular disease associated with Lp(a):

∙ Sandra Revill Tremulis, survivor and founder of Lipoprotein(a) Foundation

∙ Celina Edelstein, University of Chicago research scientist and Dr Scanu’s colleague

∙ Henry Ginsberg, MD Columbia College of Physicians and Surgeons and Chief Medical Officer for The Lipoprotein(a) Foundation

∙ Monica Stokes, International Museum of Surgical Science

View source version on businesswire.com: https://www.businesswire.com/news/home/20181109005006/en/

Editor Details

Last Updated: 09-Nov-2018